Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Clearside BiomedicalCyclerion TherapeuticsMonopar TherapeuticsAdamas PharmaceuticalsGenprex
SymbolNASDAQ:CLSDNASDAQ:CYCNNASDAQ:MNPRNASDAQ:ADMSNASDAQ:GNPX
Price Information
Current Price$2.15$5.39$7.85$2.98$3.12
52 Week RangeBuyN/ABuyHoldBuy
Beat the Market™ Rank
Overall Score1.30.71.51.51.3
Analysis Score3.30.03.53.23.5
Community Score2.72.53.12.82.4
Dividend Score0.00.00.00.00.0
Ownership Score0.01.01.01.00.0
Earnings & Valuation Score0.60.00.00.60.6
Analyst Ratings
Consensus RecommendationBuyHoldBuyHoldBuy
Consensus Price Target$5.75N/A$42.00$16.14$5.00
% Upside from Price Target167.44% upsideN/A435.03% upside441.71% upside60.26% upside
Trade Information
Market Cap$99.61 million$160.70 million$83.48 million$74.34 million$106.45 million
Beta1.071.25N/A1.68-0.9
Average Volume467,977188,2483,791462,5191,369,987
Sales & Book Value
Annual Revenue$2.17 million$4.51 millionN/A$54.64 millionN/A
Price / Sales44.4633.16N/A1.54N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.25 per share$3.56 per share$1.19 per share($0.03) per share$0.15 per share
Price / Book8.601.51N/A-99.33N/A
Profitability
Net Income$-30,770,000.00$-123,010,000.00$-4,220,000.00$-105,190,000.00$-10,650,000.00
EPS($0.81)N/A($0.45)($3.80)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/A∞N/AN/A3.47
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-293.61%-1,917.30%N/A-160.44%N/A
Return on Equity (ROE)-165.19%-96.31%-45.32%-806.54%-157.02%
Return on Assets (ROA)-67.98%-54.87%-42.72%-53.66%-146.08%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.08%0.58%N/A6.72%N/A
Current Ratio1.71%6.13%28.64%5.61%34.48%
Quick Ratio1.71%6.13%28.64%5.38%33.21%
Ownership Information
Institutional Ownership Percentage25.74%66.78%0.17%55.33%2.59%
Insider Ownership Percentage10.60%N/A48.40%24.90%29.01%
Miscellaneous
Employees50N/A4159N/A
Shares Outstanding44.87 million27.75 million10.63 million28.16 million32.85 million
Next Earnings Date8/5/2020 (Estimated)8/10/2020 (Estimated)8/6/2020 (Estimated)8/13/2020 (Estimated)8/11/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.